🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. Vincristine placebo, VINCRISTINE , Polivy 140 mg powder for concentrate for solution for infusion., MabThera 500 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Previously Untreated Diffuse large B-cell lymphoma (DLBCL)

    phase 3 small molecule active

    1 trial

  2. Viread 245 mg film-coated tablets, Viread 123 mg film-coated tablets, Viread 204 mg film-coated tablets, PTM Tenofovir DF, Viread 163 mg film-coated tablets, Viread 33 mg/g granules

    Gilead Sciences Pty Limited

    Hepatitis B Infection

    phase 3 small molecule active

    1 trial

  3. Virtual Reality Exposure Therapy - Dynamic

    Camp4 Therapeutics Corp

    Post Traumatic Stress Disorder

    phase 3 other active

    1 trial

  4. Visilizumab

    The First People's Hospital of Lianyungang

    Immunotherapy

    phase 3 small molecule active

    1 trial

  5. Vitamin A

    United Therapeutics Europe Ltd

    Sepsis

    phase 3 other completed

    1 trial

  6. Vitamin D3

    Hospital Authority, Hong Kong

    Lupus Erythematosus, Systemic

    phase 3 small molecule completed

    1 trial

  7. Vocabria 600 mg prolonged-release suspension for injection, REKAMBYS 900 mg prolonged-release suspension for injection

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 3 small molecule active

    1 trial

  8. Vonoprazan

    Takeda

    Helicobacter Pylori

    phase 3 small molecule completed

    1 trial

  9. Vonoprazan

    Takeda

    Healthy Volunteers

    phase 3 small molecule completed

    1 trial

  10. Vonoprazan

    Phathom Pharmaceuticals

    Helicobacter Pylori Infection

    phase 3 small molecule completed

    1 trial

  11. Vortioxetine

    COGNITION THERAPEUTICS INC

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  12. Vortioxetine

    The University of Hong Kong

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  13. Voucher-Based Reinforcement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-related Disorders

    phase 3 other completed

    1 trial

  14. Vutrisiran

    Alnylam Netherlands B.V.

    Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

    phase 3 small molecule active

    2 trials

  15. Vyvgart 1 000 mg solution for injection

    argenx

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  16. Vyvgart 1 000 mg solution for injection in pre-filled syringe, Placebo PH20 SC

    argenx

    Ocular Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  17. Vyvgart 20 mg/mL concentrate for solution for infusion

    argenx

    Generalized Myasthenia Gravis (gMG)

    phase 3 small molecule active

    1 trial

  18. Vyvgart 20 mg/mL concentrate for solution for infusion

    argenx

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  19. Warfarin

    United Therapeutics Europe Ltd

    Subsegmental Pulmonary Embolism Nos

    phase 3 small molecule active

    1 trial

  20. Warfarin

    Boehringer Ingelheim

    Thromboembolism

    phase 3 small molecule completed

    1 trial

  21. Warfarin Sodium

    Hospital Authority, Hong Kong

    Indications for Warfarin Therapy

    phase 3 small molecule active

    1 trial

  22. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, KAI-9531

    Kailera Therapeutics

    Obesity

    phase 3 small molecule active

    1 trial

  23. Wheat Soy Blend (WSB++)

    United Therapeutics Europe Ltd

    Stunting

    phase 3 other completed

    1 trial

  24. Wobenzym® N

    Atrium Therapeutics

    Knee Osteoarthritis

    phase 3 other terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources